ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

AVGO vs ORCL // DIVIDEND YIELD & FCF PAYOUT SAFETY

Broadcom Inc. (NASDAQ) VS. Oracle Corporation (NYSE) • 15-METRIC TALLY: AVGO 10 — ORCL 4
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: ORCL
dividend-safety
0.80%
dividend-safety
1.53%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AVGO VS. ORCL) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC AVGO ORCL SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 68.77% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 24.73% 11.39% +13.34 AVGO /roic <GO>
EV/EBITDA & P/E Valuation 34.1x 17.9x +16.20 ORCL /valuation <GO>
Free Cash Flow Yield 2.55% -7.07% +9.62 AVGO /fcf-yield <GO>
Operating Margin 48.05% 32.12% +15.93 AVGO /operating-margins <GO>
Net Profit Margin 42.94% 26.36% +16.58 AVGO /net-margins <GO>
Revenue Growth (YoY) 48.69% 21.62% +27.07 AVGO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.80% 1.53% -0.73 ORCL /dividend-safety <GO>
Altman Z-Score & Debt/Equity 12.08 1.54 +10.54 AVGO /balance-sheet <GO>
Piotroski F-Score Quality 8/9 6/9 +2.00 AVGO /piotroski-score <GO>
Options Implied Move & Put/Call Skew 8.98% 11.57% -2.59 AVGO /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 40.8 45.6 -4.86 ORCL /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.82 1.37 +0.45 AVGO /macro-sensitivity <GO>
Forward P/E Multiple 19.0x 16.5x +2.47 ORCL /forward-pe <GO>
Enterprise Scale & Market Cap $1.55T $405.97B $1.14T AVGO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR AVGO REV ORCL REV AVGO GROSS % ORCL GROSS % AVGO FCF ORCL FCF
FY 2026 — $67.36B — — — -$23.69B
FY 2025 $63.89B $57.40B 67.8% — $26.91B -$394.0M
FY 2024 $51.57B $52.96B 63.0% — $19.41B $11.81B
FY 2023 $35.82B $49.95B 68.9% — $17.63B $8.47B
FY 2022 $33.20B $42.44B 66.5% — $16.31B $5.03B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AVGO // BETA 1.82
VIXCLS -0.51 r
UMCSENT +0.22 r
INDPRO -0.21 r
ORCL // BETA 1.37
VIXCLS -0.35 r
UNRATE +0.19 r
PCEPI -0.17 r